R&D News | pharmaphorum

News

Gilead’s twice-yearly HIV PrEP 100% effective, says study

Gilead Sciences’ already dominant position in HIV pre-exposure prophylaxis (PrEP) has been consolidated by a new study showing that its twice-yearly injectable drug was 100% effective in pr

News

Infectious disease group ISID names six global priorities

The non-profit International Society for Infectious Diseases (ISID) has published a set of six priorities focusing on the challenges faced by low- and middle-income countries (LMICs) ahead

News

Jacob Simmering, PhD, University of Iowa assistant professor of internal medicine

Prostate drugs may find role in dementia, say US scientists

Dementia with Lewy bodies (DLB) may not be as well-known as other forms like Alzheimer’s, but is just as devastating, so the discovery that commonly used drugs may reduce the risk of the di

News

Marea’s $190m double round heads latest biotech financings

Our latest round-up of biotech financings includes nine-figure rounds for Marea, Santa Ana Bio, and Opthea, with InduPro, Elion, and iOnctura also in on the action.

News

Blood test could spot Parkinson’s years earlier

An artificial intelligence-powered blood test that may be able to predict Parkinson’s disease several years before symptoms start to develop could allow earlier treatment and help guide the

News

AZ has another setback with Truqap after failed TNBC trial

AstraZeneca’s first-in-class pan-AKT inhibitor Truqap was unable to improve overall survival (OS) in a phase 3 trial in triple-negative breast cancer (TNBC), denting the prospects of the ne

Gilead’s twice-yearly HIV PrEP 100% effective, says study

Infectious disease group ISID names six global priorities

Prostate drugs may find role in dementia, say US scientists

Marea’s $190m double round heads latest biotech financings

Blood test could spot Parkinson’s years earlier

AZ has another setback with Truqap after failed TNBC trial

Bankruptcy threat looms as Quince runs out of options

How to meet your physicians where they are online

News

Editor's Picks